November 7, 2023
The University of Cincinnati Cancer Center’s Vladimir Bogdanov found a new drug developed in his lab was effective at preventing pancreatic cancer growth and spread when combined with chemotherapy in lab tests.
November 13, 2023
A new clinical trial underway at the UC Gardner Neuroscience Institute is applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
November 15, 2023
Clinical Research News highlighted recommendations to improve recruitment in acute stroke trials, led by UC's Joseph Broderick, following the Stroke Treatment Academic Industry Roundtable XII earlier this year.
February 7, 2024
University of Cincinnati neurology experts are presenting research at the International Stroke Conference 2024, Feb. 7-9 in Phoenix, Arizona.
February 15, 2024
The University of Cincinnati Cancer Center announced it is opening the Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, this summer.
March 18, 2024
An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
February 29, 2024
A University of Cincinnati Cancer Center study published in the journal JAMA Network Open found real-time navigation is a useful tool for surgeons performing ablation procedures to destroy tumors in the liver.
February 20, 2024
The University of Cincinnati Cancer Center is the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
March 6, 2024
University of Cincinnati Cancer Center researchers in the lab of Jun-Lin Guan, PhD, have identified a new protein that helps prevent metastasis of a subset called HER2-positive breast cancer.
May 1, 2024
Researchers at the University of Cincinnati and Dell Medical School at the University of Texas at Austin are leading a study using state-of-the-art neuroimaging techniques and artificial intelligence to identify changes in the brains among children of adults living with bipolar disorder.